Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ruilian Guo"'
Autor:
Xiaoxin Zhong, Haifeng Li, Qian Chen, Peng Hao, Tong Chen, Hantao Mai, Kelin Zhang, Guifang Zhong, Ruilian Guo, Huihua Cheng, Benhua Jiang, Sicong Zhu, Suyuan Zhuang, Haoran Li, Yantao Chen, Qing He
Publikováno v:
BMC Anesthesiology, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Sepsis is a life-threatening organ dysfunction caused by the infection-related host response disorder. Adequate mean arterial pressure is an important prerequisite of tissue and organ perfusion, which runs through the treatment of
Externí odkaz:
https://doaj.org/article/f0d10675e68e4c1ea44fdf7516c0e367
Autor:
Qing He, Peng Hao, Gang He, Hantao Mai, Wenzhou Liu, Weiqiong Zhang, Kelin Zhang, Guifang Zhong, Ruilian Guo, Changzhi Yu, Yang Li, Chipiu Wong, Qian Chen, Yantao Chen
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Doxorubicin (Dox) is the standard treatment approach for osteosarcoma (OS), while acquired drug resistance seriously attenuates its treatment efficiency. The present study aimed to investigate the potential roles of metabolic reprogramming a
Externí odkaz:
https://doaj.org/article/dd785fd8469b467992a1fb0c652956d4
Autor:
Hantao Mai, Peng Hao, Yantao Chen, Qian Chen, Yang Li, Guifang Zhong, Ruilian Guo, Chipiu Wong, Qing He, Kelin Zhang, Changzhi Yu
Publikováno v:
Cell Biology and Toxicology.
Chemotherapy resistance is an important problem for clinical therapy of osteosarcoma (OS). The potential effects of histone deacetylases (HDACs) on OS chemoresistance are studied. The expression of HDACs in OS cells resistance to doxorubicin (Dox) an
Publikováno v:
Journal of Cellular and Molecular Medicine
Chemotherapy resistance is one of the major challenges for the treatment of osteosarcoma (OS). The potential roles of oestrogenic signals in the chemoresistance of OS cells were investigated. As compare to the parental cells, the doxorubicin and cisp